Heming Lu

526 total citations
25 papers, 409 citations indexed

About

Heming Lu is a scholar working on Otorhinolaryngology, Surgery and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Heming Lu has authored 25 papers receiving a total of 409 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Otorhinolaryngology, 10 papers in Surgery and 10 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Heming Lu's work include Head and Neck Cancer Studies (15 papers), Head and Neck Surgical Oncology (6 papers) and Advanced Radiotherapy Techniques (5 papers). Heming Lu is often cited by papers focused on Head and Neck Cancer Studies (15 papers), Head and Neck Surgical Oncology (6 papers) and Advanced Radiotherapy Techniques (5 papers). Heming Lu collaborates with scholars based in China, United States and Switzerland. Heming Lu's co-authors include Min Yao, John M. Buatti, Gerry F. Funk, Huaming Tan, Qiang Pang, Kristi Chang, Shan Deng, Judith Wacha, Kenneth J. Dornfeld and Lucy Hynds Karnell and has published in prestigious journals such as International Journal of Radiation Oncology*Biology*Physics, Frontiers in Immunology and Cancer Treatment Reviews.

In The Last Decade

Heming Lu

23 papers receiving 404 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Heming Lu China 12 284 176 151 105 100 25 409
Esengul Kocak–Uzel United States 10 262 0.9× 160 0.9× 237 1.6× 102 1.0× 137 1.4× 13 460
Karin Söderkvist Sweden 9 79 0.3× 106 0.6× 114 0.8× 65 0.6× 58 0.6× 32 279
Mary Lei United Kingdom 13 253 0.9× 157 0.9× 155 1.0× 144 1.4× 44 0.4× 32 415
Ang Qu China 12 69 0.2× 195 1.1× 156 1.0× 76 0.7× 144 1.4× 43 406
Anussara Prayongrat Thailand 11 119 0.4× 93 0.5× 131 0.9× 88 0.8× 86 0.9× 43 298
Víctor A. Marcial-Vega United States 8 174 0.6× 118 0.7× 104 0.7× 89 0.8× 94 0.9× 12 321
Danita Kannarunimit Thailand 13 296 1.0× 146 0.8× 188 1.2× 148 1.4× 86 0.9× 27 425
Andrew Lauve United States 8 197 0.7× 138 0.8× 341 2.3× 80 0.8× 440 4.4× 11 588
Steffen Hennies Germany 13 52 0.2× 174 1.0× 191 1.3× 162 1.5× 89 0.9× 15 365
Chaosu Hu China 8 125 0.4× 71 0.4× 87 0.6× 90 0.9× 30 0.3× 47 261

Countries citing papers authored by Heming Lu

Since Specialization
Citations

This map shows the geographic impact of Heming Lu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Heming Lu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Heming Lu more than expected).

Fields of papers citing papers by Heming Lu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Heming Lu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Heming Lu. The network helps show where Heming Lu may publish in the future.

Co-authorship network of co-authors of Heming Lu

This figure shows the co-authorship network connecting the top 25 collaborators of Heming Lu. A scholar is included among the top collaborators of Heming Lu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Heming Lu. Heming Lu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Cheng, Yao, Liqiang Wu, Suying Lü, et al.. (2025). 336P: Durvalumab (D) as consolidation therapy for limited-stage small-cell lung cancer (LS-SCLC): ADRIATIC China subgroup analysis. Journal of Thoracic Oncology. 20(3). S203–S204.
2.
Liu, Xu, Hailan Jiang, Xin Qi, et al.. (2023). Interobserver Variations in Target Delineation in Intensity-Modulated Radiation Therapy for Nasopharyngeal Carcinoma and its Impact on Target Dose Coverage. Technology in Cancer Research & Treatment. 22. 3 indexed citations
3.
Meng, Lingzhang, Heming Lu, Jingjie Zhao, et al.. (2022). Human papillomavirus infection can alter the level of tumour stemness and T cell infiltration in patients with head and neck squamous cell carcinoma. Frontiers in Immunology. 13. 1013542–1013542. 4 indexed citations
4.
Wei, Qiang, et al.. (2021). Hyperprogression After Immunotherapy for Primary Small Cell Neuroendocrine Carcinoma of the Ureter: A Case Report. Frontiers in Oncology. 11. 696422–696422. 3 indexed citations
5.
Liu, Xu, Hao Chen, Hailan Jiang, et al.. (2021). A Clinical-Radiomics Nomogram Based on Computed Tomography for Predicting Risk of Local Recurrence After Radiotherapy in Nasopharyngeal Carcinoma. Frontiers in Oncology. 11. 637687–637687. 22 indexed citations
6.
Lu, Heming, Yuying Wu, Xu Liu, et al.. (2021). The Role of Dynamic Contrast-Enhanced Magnetic Resonance Imaging in Predicting Treatment Response for Cervical Cancer Treated with Concurrent Chemoradiotherapy. Cancer Management and Research. Volume 13. 6065–6078. 4 indexed citations
7.
Wu, Yuying, Hailan Jiang, Pei Liu, et al.. (2020). <p>Long-Term Results of Concurrent Chemoradiotherapy Combined with Anti-EGFR Monoclonal Antibody Prior to Surgery in Locally Advanced Cervical Cancer: A Single-Institute Prospective Study</p>. Cancer Management and Research. Volume 12. 12309–12317. 3 indexed citations
8.
Lu, Heming, Yuying Wu, Hailan Jiang, et al.. (2018). A prospective study on neoadjuvant chemoradiotherapy plus anti-EGFR monoclonal antibody followed by surgery for locally advanced cervical cancer. OncoTargets and Therapy. Volume 11. 3785–3792. 16 indexed citations
9.
Deng, Shan, Xu Liu, Heming Lu, et al.. (2017). Three-Phase Adaptive Radiation Therapy for Patients With Nasopharyngeal Carcinoma Undergoing Intensity-Modulated Radiation Therapy: Dosimetric Analysis. Technology in Cancer Research & Treatment. 16(6). 910–916. 11 indexed citations
10.
Wu, Fang, Rensheng Wang, Heming Lu, et al.. (2016). Comparison between nedaplatin and cisplatin plus docetaxel combined with intensity-modulated radiotherapy for locoregionally advanced nasopharyngeal carcinoma: a multicenter randomized phase II clinical trial.. PubMed. 6(9). 2064–2075. 29 indexed citations
11.
Lu, Heming, Guosheng Feng, Hailan Jiang, et al.. (2015). Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy. Radiation Oncology. 10(1). 192–192. 34 indexed citations
12.
Huang, Lianfen, et al.. (2015). Automatic Computer-Aided Diagnosis of Liver Disease Based on Multi-Cascade and Multi-Featured Classifier. Journal of Medical Imaging and Health Informatics. 5(2). 322–325. 4 indexed citations
15.
Lu, Heming, Jiaxin Chen, Yanrong Hao, et al.. (2010). Intrathoracic Endotracheal Metastasis from Nasopharyngeal Carcinoma:A First Case Report and Review of the Literature. Case Reports in Oncology. 3(2). 160–164. 3 indexed citations
17.
Lu, Heming, Yanrong Hao, Jiaxin Chen, et al.. (2009). Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: A treatment paradigm also applicable to patients in Southeast Asia. Cancer Treatment Reviews. 35(4). 345–353. 42 indexed citations
18.
Lu, Heming, Min Yao, & Huaming Tan. (2008). Unknown primary head and neck cancer treated with intensity-modulated radiation therapy: To what extent the volume should be irradiated. Oral Oncology. 45(6). 474–479. 22 indexed citations
19.
Yao, Min, Kristi Chang, Gerry F. Funk, et al.. (2007). The Failure Patterns of Oral Cavity Squamous Cell Carcinoma After Intensity-Modulated Radiotherapy—The University of Iowa Experience. International Journal of Radiation Oncology*Biology*Physics. 67(5). 1332–1341. 69 indexed citations
20.
Yao, Min, et al.. (2007). Health-Related Quality-of-Life Outcomes Following IMRT Versus Conventional Radiotherapy for Oropharyngeal Squamous Cell Carcinoma. International Journal of Radiation Oncology*Biology*Physics. 69(5). 1354–1360. 48 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026